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A PROSPECTIVE STUDY OF VARIOUS CNS 
MANIFESTATIONS ASSOCIATED WITH HIV/AIDS AND TO 
STUDY A RELATIONSHIP BETWEEN IT AND CD4 COUNTS 
 
BACKROUND: 
                         AIDS is a disease caused by human immunodeficiency virus and 
featured by immunosuppression leading on to opportunistic infection secondary 
neoplasm’s and neurological manifestations. According to WHO HIV is a 
pandemic. The mortality due to opportunistic infection is more. The 
opportunistic infection occurred when there was a decrease of cd4 counts. 
 
METHODS: 
                    A prospective study was conducted in Thanjavur medical college 
thanjavur with an objective to determine the various CNS manifestations 
associated with HIV and its relation with the CD4 counts. All the seropositive 
aged more than 14 yrs with CNS manifestations where included in the study. 
Clinical examinations, CT, MRI, serology, CSF analysis were done and diseases 
where diagnosed based on respective criteria’s. CD4 counts where done and co 
related with the diagnosis. A total of  40 cases were studied. 
RESULTS: 
                 The infection was common among males. The people aged between 
30-39 where affected the most. Tuberculosis was the most common infection. 
Toxoplasma and tuberculoma presented with focal neurological signs. One case 
of progressive multifocal keukoencephalopathy was observed, he presented 
with seizures. Seizure was also seen with toxoplamosis  and  
neurocysticercoisis. Most of qall the cases had headache as the commonest 
symptom.CNS TB had mean CD4 count of 217, cyptococcal meningitis had a 
mean count of 130, toxoplasmosis with a mean count of 104, PML with 
286.Two cases of stoke were observed and it was attributed to direct virus 
infection and they had a mean count of 323. Three cases of the 22 tb cases had 
TB lymphadenitis, intestinal TB AND TB pericarditis. 
 
CONCLUSION: 
                         The various cns manifestations studied were TB meningitis, 
cryptococcal meningitis, tuberculoma, toxoplasmosis, PML, stoke, ATM. TBM 
was the most common infection observed. TB occurred over a range of CD4 
counts so cannot be used as a AIDS defining illness. The mortality for CNS TB 
was more when it occurred with low CD4 counts. Headache was the most 
common presentation. 
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INTRODUCTION 
IT was in 1983, the cause of acquired immunodeficiency syndrome was 
identified as human immunodeficiency virus type-1. Almost 28 years have 
elapsed since discovery,and through these years it has been changed from a fatal 
disease to a treatable chronic diseases. The greatest discovery in the history of 
medicine was the discovery of Anti retro viral theraphy for AIDS that has made 
the condition treatable. However still largely many people of the developing and 
third world countries are inaccessible to ART. 
GLOBAL SCENARIO 
Antiviral therapy and increased incidence of HIV has increased the number of 
people living with HIV. According to  data in the 2010 AIDS epidemic update 
(1)because of HAART and population growth more people are living with 
AIDS and the death rate has come down by 10% saving nearly 2.9 million 
people. There is a 17% reduction in death during the past 8 years. (2001. United 
nation declaration of commitment on HIV/AIDS.[1])  
SCENARIO IN INDIA 
Despite being the world’s 3rd biggest population affected by HIV/AIDS (south 
Africa and Nigeria), the disease prevalence is lower than other countries.1.4-1.6 
million have HIV in India and there is a 50% decrease in incidence with the 
epidemics being stable at the national level(BMJ). Gender disparity, labour, 
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migration, illetracy largely contribute to the spread of the diseases. Available 
data shows stable figures at national level.   
The estimated adult HIV prevalence was 0.31% in 2009. The states with high 
HIV prevalence rates include Manipur (1.40%), Andhra Pradesh (0.90%), 
Mizoram (0.81%), Nagaland (0.78%), Karnataka (0.63%) and Maharashtra 
(0.55%).The adult HIV prevalence in India is declining from estimated level of 
0.41% in 2000 through 0.36% in 2006 to 0.31% in 2009. 
SCENARIO IN TAMILNADU 
TANSACS (TAMILNADU STATE AIDS CONTROL SOCIETY) is a 
government organization that is responsible for the prevention, treatment and 
supportive measures in the state. According to the NACO 2011 AIDS 
STATISTICS of TAMILNADU , HIV prevalence in antenatal clinic is 
0.25%,prevalence in STD clinic is 8.00%, prevalence amoung drug users is 
16.80%,prevalence amoung sex workers is 4.68%. 
HIV AND OPPORTUNISTIC INFECTION 
Apart from the virus, opportunistic infections contribute considerably to the 
mortality amoung AIDS cases. The level of immune suppression and the 
endemicity of the agent determine the incidence of the infection. Tuberculosis 
(TB), amoebiasis and leishmanias have higher incidence amoung HIV infected 
patients.  
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CNS MANIFESTATION IN HIV/AIDS 
Neurological manifestations are seen ail through the course of the illness from 
the prodromal stage to the terminal stage and any part of the neuroaxis can be 
involved. Symptomatic illness develops in 50% of cases and pathological 
lesions are demonstrated in 90% of the pathological specimens at autopsy. CNS 
manifestations can either be due to the virus or opportunistic infection. IT can 
also be demylenating or degenerative in nature. The manifestations depend on 
the prevailing endemic infections, literacy status, accessibility to ART and 
nutitional status. 
There have been only few studies regarding neurological manifestations in 
PLWHA. Poone medical research foundation (7) have reported crypticoccal 
meningitis was commoner than TB meningitis.Amongst mass lesions CNS 
Tuberculoma and toxoplasmosis was the most common cause.Several studies 
have reports opportunistic infections were the leading cause  of mortality and 
CNS tuberculosis was not A good predictor of advanced STAGE OF ILLNESS. 
CNS tuberculosis was relatively more in earlier stages of the disease. AIDS-
DEMENTIA complex (ADC) and CNS malignancies were very rare.There has 
been only few studies from our centre and from our state, inspiring us for this 
study. Our hospital is a tertiary care centre and a large number of patients have 
been reported as PLWHA.  
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AIMS AND OBJECTIVES 
Keeping in view of above facts a prospective study will be conducted in 
department of medicine, THANJAVUR MEDICAL COLLEGE. THANJAVUR 
between JAN 2012- OCT 2012 with an objective to determine the various CNS 
manifestations associated with HIV/AIDS and to establish a relationship 
between occurrences of it with the CD4 count.  
 
  
6 
 
ACQUIRED IMMUNODEFICIENCY SYNDROME 
DEFINITION 
AIDS is a disease caused by retrovirus human immunodeficiency virus & 
characterized by profound immunosuppression that leads to opportunistic  
infections , secondary neoplasms & neurologic manifestations. 
 
HIV is a pandemic according to WHO. Death toll due to AIDS is 25 million 
people(1981-2006).[13]  HIV infects about 0.6% of the earth population.[13] the 
prevalence in 2004 was 2.1 million to the present 2.1 million in 2010
[14]
.  A 
disproportionate number of AIDS deaths(260000 children in 2010 [14]) 
occurred  in Africa, bringing down the GDP and increasing the number people 
below poverty line.[15] HIV is estimated to infect atleast 90 million people in 
Africa producing 18 million orphans. Since the detection of HIV in 1984 ,it has 
been extensively studied,its molecular and cellular biology is now better 
understood than that of any other virus. 
 
AIDS is caused by Human immunodeficiency virus. It is very small and fragile 
virus belonging to retro virus family.The virus infects the helper T cells of 
immune system(mainly CD4 cells, dentritic cells,macrophages). These cells 
harbor mature viruses in lymph nodes and lymphoid organs and   continue to 
infect other immune cells, in a more vigorous way. There is continuous decrease  
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in cell count,with a explosive increase in viral load.  After reaching a peak viral 
concentration,a gradual decrease is observed. 
  
 HIV  SUBTYPES 
HIV  can be classified into 2 types based on genetics and antigen into HIV
the cause of the ongoing pandemic and HIV
otherwise. HIV  type 1 is  linked to   P troglodytes(SIV cpz),while HIV type2 
(HIV-2)  to the sooty mangabey virus (SIV smm). HIV
based on the env gene in to groups M,O,N and groups M into subtypes A
K(9).Most research is on subtype B, seen in western countries and japan. Africa 
habours A and AG while INDIA habour
 
-2, seen in west Africa but rare 
-1 can be classified 
s C. 
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HIV STRUCTURE 
 
 
HIV 1 is made of 2 mRNA copies (positive sensed).Each strand >9700 
nucleotides long and is associated with helical nucleocaspid (p9/6). The 
icosohedral capsid (p24) covers the above complex. This environment contains 
the reverse transcriptase.The matrix protein surrounds the caspid. The envelope 
of the virus(go140 &gp41) is derived from the host cell membrane.  
 The first prototype of its structure designed in 2006 using cryoelectron 
microscopy showed TRIMER  of gp120-gp41 .[15] However later a compact 
single-stalk "mushroom" prototype was published.[16] Recent evidence however 
backs the trimer prototype.  
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THE COURSE OF AIDS: 
HIV usually enters the body(most frequiently by sexual route) infects 
macrophages and dentritic cells invading mucosal tissues as they are primary 
line of defence. Dendritic cells pileup  the viral particles on to their surfaces(by 
gp140) but fails to internalize them. 
 
Opportunistic infection in hiv/aids HIV  poduces the largest number of 
deaths.Though HIV does not kill, it weakens the human immune system and 
making the person vulnerable for infection which are rarely seen in those with 
normal immune system.Such Infections seen in the immuno suppresed are 
called opportunistic infections.(10) 
 
Opportunistic infections and its complications creates  a considerable proportion 
of  mortality. The  level of immune suppression decides the infection.( 
occurring at CD4  counts  <200or total lymphocyte count 
<1200).Tuberculosis,amoebiasis and leishmaniasis occur more frequently in 
HIV infected patients. Many of these opportunistic infections  seen in advanced 
stages of the diseases are called  AIDS defining illness 
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CNS  MANIFESTATIONS OF HIV 
The nervous system is a vulnerable target for HIV infection(40% to 70% HIV 
people). [19] . The CNS complications of AIDS are neurocognitive dysfunction 
and HIV-associated dementia (HAD;    HIV encephalopathy), vasculitis, 
demylenation[21,22]. Secondary infections  due to immunosupresion.  
HAD is dreadful CNS complication of HIV infection. [30] Milder form of 
impairment is called    HIV-associated minor cognitive/motor disorder 
(MCMD). 
HIV Dementia 
 In 1992, 7.3% AIDS cases were said to have HIV Dementia(Centers for 
Disease Control and Prevention database)[42].One of the difficult to understand 
sequlae of HIV infection of the brain is HIV dementia .  The term HIV-
associated neuro cognitive disorders (HAND) extends from asymptomatic 
neuro cognitive dysfunction through minor neurocognitive disorder  to 
clinically severe dementia. Symptoms of HAD can be futher divided into 3 
main types: cognitive, motor and behavioral [33].    The primary cognition 
affected is memory loss with mental and motor retardation  and signs being 
ataxia and weakness. The behavioral symptoms such as apathy and social 
withdrawal are commonly seen and are often mistaken for depression.  ADC  
develops after many years of latency and is associated with low CD4 counts and 
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increased viral load. The yearly  incidence of HAD in developed countries 
before HAART was 7%, (cumulative risk = 5-20%).With HAART, the 
incidence of HAD began to decrease, but it increasing again. Indian based 
studies show a  prevalence of 1-2% as clad C hiv virus is prevalent in india. 
 
Initial presentation may be too elusive to arrive at a  clinical diagnosis. 
Neuropsychological tests to detect milder dysfunction  serves as  quantitative 
markers of disease progression [34-35]. As dementia advances, cognitive 
dysfuntion becomes more manifest( with psychomotor slowing  and marked 
behavioral aberrance).Signs such as paraparesis, incontinence, tremor, and 
seizures are seen at this stage. 
 
Study by  rakendra singh etal  in Punjab in  2009 (158)  showed HAD to cause 
significant morbidity(33.65%), CNS infections succeds(21.63%) . Most other 
Indian studies revealed less prevalence of HIV dementia. 
PATHOPHYSIOLOGY 
HIV  infecting the monocytes and CD4+ cells, enters the brain.  
Immunohistochemistry revealed dense virus concentration in sudcortical gray 
matter. Autopsy also proves the predominant subcortical deep gray involvement 
( basal ganglia, thalamus). The mechanism how HIV infection of the CNS leads 
to neurocognitive disorders  is the subject of intense research.sidits and price 
[37] deviced a scale for AIDS dementia complex , normal(grade 0) to end 
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vegetative state (grade 4).The memorial sloan kettering scale for the aids 
dementia complex is also used. 
Diagnostic criteria(9) 
1. Marked acquired impairment of at least two ability domains of cognitive 
function.  
2. Cognitive impairments identified in 1. interfere markedly with day-to-day 
activities. 
3. Cognitive impairments identified in 1. are present for at least one month. 
4. Cognitive impairments identified in 1. do not meet the criteria 
for delirium. 
5. No evidence of another, pre-existing aetiology that could explain the 
dementia. (e.g. a CNS neoplasm, cerebrovascular disease). 
Diagnostic Studies 
Neuroimaging 
Computed tomography (CT) and MRI studies helps to prove ADC and rule out 
other diagnosis     (infections or neoplasms). CT can shows diffuse cortical 
atrophy, ventricular enlargement, and Basal ganglia calcifications. 
Neuroimaging results may be normal in early stages. 
 MRI(T2- weighted) shows hyperintense lesions in the periventricular white 
matter and centrum semiovale. The lesions are patchy initially and spreads as 
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the pathology advances. Differential diagnosis are multiple sclerosis (MS) and 
small-vessel disease.(159) 
MRI OF PATIENT WITH HIV DEMENTIA 
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ADC and effect of HAART 
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Algorithm for Dementia 
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Treatment 
Highly active antiretroviral therapy (HAART) is the basis for the management 
of HIV-related  cognitive disorder. HAART is shown to produce a decline in  
the rate of dementia from 50% to 10%  and partly reverses of 
neuropsychological deficits.[43]HAART protects from and abates the incidence 
of AIDS dementia complex and HIV-associated progressive encephalopathy. 
Stroke Syndromes 
Strokes and TIAs can occur in HIV patients(1.5% of advanced HIV). Though 
mostly due to opportunistic infection, in more than half there is no attribute 
apart from the HIV virus itself. A complex mix of effects of anticardiolipin Ab, 
decreased protein S levels, and dysfunctional heparin cofactor II  creates a 
prothrombotic state and vasculitis produced by the virus itself with significant 
overlap between the two is attributed as the cause.Uncontroled release of TNF 
alpha and interleukin-1 in advanced stages appends to the thrombophilia that 
exist.[46]. Brew and colleagues[44] found the mean CD4+ cell count to be 130 
± 80 cells/mcL, with most having CD4+ cell counts < 50 cells/mcL. 
Alaka K Deshpandeand Mrinal M Patnaik study in Mumbai of 300 hiv 
infected cases revealed (160)  67 (22.3%) had CNS manifestations attributable 
to the direct effects of HIV. The presentations were stroke (29.8%), 
demyelination(5.9%), HAD (5.9%), and venous thrombosis (4.4%), peripheral 
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neuropathy (35.8%), spinal cord disease (5.9%), and a case of myopathy. These 
findings closely co related with their CD4 counts. 
MRI with angiograms showed focal segmental narrowing of vessel walls. 
However, CSF examination are negative for any antibodies, (VARICELLA and  
CMV , VDRL) thereby concluding vasculitis as a direct effects of HIV. 
HIV Myelopathy 
Myelopathy was present in ~20% of patients with AIDS, often as part of HIV 
encephalopathy.  This condition is pathologically similar to subacute combined 
degeneration( pernicious anemia).  vitamin B12 deficiency  seen in patients with 
AIDS as a primary complication of HIV infection does not appear to be 
responsible for the myelopathy . Since the introduction of HAART, there are 
less than 10% of AIDS patients who develop HIV myelopathy. In Indian studies 
HIV  myelopathy was reported rarely. 
 
CLINICAL PRESENTATION 
Characterized by a subacute onset , presents with gait disturbances, 
predominantly ataxia and spasticity; it may progress to include bladder and 
bowel dysfunction.(46) 
Physical findings include evidence of increased deeptendon reflexes and 
extensor plantar responses.The second form of spinal cord disease involves the 
dorsalcolumns and presents as a pure sensory ataxia.The third form is also 
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sensory in nature and presents with paresthesias and dysesthesias of the lower 
extremities. 
Diagnostic Tests 
1. CSF analysis can exclude infection with CMV,VCZ,HSV, HTLV-1, and 
HTLV-2. CSF results are usually normal in HIVmyelopathy. 
2.Serum vitamin B-12 and folic acid levels. (B-12 levels are usually normal in 
vacuolar myelopathy). 
3.A Schilling test, hematologic studies, and CD4+ lymphocyte counts may be 
indicated. 
There can be atrophy of the thoracic or cervical cord segments. T2-weighted 
MRI  shows symmetric nonenhancing high-signal areas, which are present on 
multiple contiguous slices and are usually symmetrical; these may result from 
extensive vacuolation.[47, 48,4 9] Lesions may be confined to the posterior 
columns, especially the gracile tracts, or may be diffuse.  
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Treatment & Management 
Care for patients with HIV-associated vacuolar myelopathy is primarily 
supportive. Viral load control with HAART is the main aim however the 
response is poor. 
Secondary Lesions of the Central Nervous System 
Toxoplasmosis 
Toxoplasmosis is caused by protozoan Toxoplasma gondii[.52] .Cats are the 
primary host. Animals are affected by ingestion of infected meat, or by spread 
from mother to fetus. Cats are the primary source of for humans. Fecal soiling 
of extremites is a important risk factor.[53] 
Toxoplasma infection is present in a third of world population.[54] The 
CDC reports a seroprevalence in US of 10.8% (NHANES) (1999-2004). 
 
Seroprevalence of antibodies against T. gondii in HIV patients reflects the rates 
of seropositivity as of the general population. Those with HIV were more likely 
to have antibodies to T. gondii if they were ≥50 years of age .Owning a cat or 
not did not affect the incidence amoung HIV patients.  
 
 Toxoplasmosis is mostly asymptomatic. Loss of cellular immunity (esp 
CD4<100) there is reactivation of the latent infection  presenting as cerebral 
toxoplamosis, however cases amoung seronegative patients are also 
reported(Renoldet al, Cohen). 
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Toxoplasma gondii ,a intracellular protozoan exists in 3 forms: the oocyst, the 
tissue cyst, and the tachyzoite. Cat is the definitive host. Oocyst excreted by the 
cat sporulate into tissue cysts(in the muscles if animals).Undercooked meat is 
the source of infection to humans.The tissue cyst form tachyzoites, which reach 
the brain heart, muscle, lungs through the blood and remain quiescent. 
Immunosuppresion cause the disease to manifest. CNS is mostly affected 
(multifocal necrotizing encephalitis) and cerebral lobes are affected.  
 
Cerebral toxoplasmosis  mostly presents as  mass lesion(cerebral cortex)in 
AIDS patients(3%-40%)  [56, 57, 59-61] .It is due to reactivation of latent  
acquired endogenous infection, as evidenced by the absence  of IgM antibodies 
[61]. It occurs in advanced stages of AIDS[60, 63]. Worldwide, T. gondii 
accounts for most of ‘focal brain lesion’ in HIV patients.The incidence of 
infection differs from country to country depending on the prevalence in the 
general population, genotypes of the organism isolated, racial foactors and 
ethnicity.  
 
CLINICAL FEATURES 
Annals states “Toxoplasma encephalitis can present with focal or generalized 
CNS manifestations [59-61] , the most frequently as headache (55%)and focal 
neurologic signs( 69%); seizures,fever and altered conciosness are also seen. 
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[60].Patients develop diffuse encephalopathy  as the disease progresses, 
subacutely over a period of  months”. 
DIAGNOSIS 
1.Computed tomography (CT) or MRI.” MRI is more sensitive,especially for 
small posterior fossa lesions. MRI often identifies two or more lesions. 
Radiological findings can be divided into typical or atypical patterns. ‘Typical’ 
patterns is seen in  80% (hypo dense ring or nodular enhanching lesion with 
perilesional edema). Atypical patterns is seen in around( hypodense lesions in 
the absence of contrast enhancement and with pressure effect)” .Tuberculoma 
and primary central nervous system lymphoma (PCNSL) are the closest 
differncial diagnosis in AIDS patients. PET SCAN and tissue biopsy help in the 
diagnosis. 
 Imaging can be normal in diffuse toxoplasmosis.A journal of radiology states 
“Single lesions  goes in favour of lymphoma than toxoplasmosis, However, 
multiple lesions are  common in toxoplasmosis.MRI is  sensitive over CT scan 
in detecting diffuse lesions”[161] 
“If the  imaging  at the beginning of the disease is normal or show focal signal 
abnormalities ( no mass lesion), a diagnosis of meningitis, AIDS dementia 
,progressive multifocal leukoencephalopathy should be entertained”. 
MRI of a Patient with Toxoplasmosis 
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CT of a Patient with Toxoplasmosis (Multiple lesion)  
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CT of a Patient with Toxoplasmosis (Single Lession) 
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If imaging shows one or more focal mass lesions with ‘impending herniation’, 
an open biopsy with decompression is indicated. Treatment (infections and 
neoplasms) is initiated, depending on biopsy results.If there is no evidence of 
herniation  futher investigatios is advised. 
Immunological Diagnosis 
There is a high prevalence of sero positivity amoung the healthy people making 
serology a less useful test for diagnosis of cerebral toxoplammosis. In 
Brazil,(8)” Serology was positive in most AIDS cases with focal lesions”. 
Dhumni and sengupta  study of national prevalence of toxoplasmosis in India 
(162) in 23,094 serum samples  with the use of a solid-phase immune capture 
ELISA.Antibodies (IgG) were found in 24.3%; IgM antibodies were detected in 
2% of the samples. The lowest sero prevalences were in the northern parts of 
India, with the highest in the south. Sero prevalence was 31.5% in 
Maharashtra,21.5% in tamil nadu, 21.2 % in Orissa,15.8% cases in delhi. These 
data probably reflect the effects of significantly drier conditions and, therefore, 
a negative impact on the survivability of T. gondii oocys. A negative serology 
does not rule out a diagnosis of cerebral toxoplasmosis and the treatment plan 
should not be altered. 
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Brain Biopsy 
Indications for brain biopsy include either of the following (161) 
• ‘Single mass lesion and negative serologic results’ 
• ‘No response to 14 days of empiric therapy’ 
TREATMENT 
Radiologic findings and detectable antitoxoplasma antibody is an indication to  
initiate empirical therapy [63]. Oral pyrimethamine (loading dose of 50 to 200 
mg/d followed by maintenance doses of 25 to 75 mg/d) and sulfadiazine (4 to 8 
g/d) for 2 to 6 weeks after treatment  produces good results [67 68], as both the 
drugs cross the blood-brain barrier  [69].  Therapy with clindamycin and 
pyrimethamine is an  also effective treatment for toxoplasma encephalitis  with 
similar results [72, 74]. A RCT found that the percentage of favorable clinical 
responses at 3 weeks in patients treated with pyrimethamine and sulfadiazine 
(79%) was same as  the percentage in those given pyrimethamine and 
clindamycin (77%) [72). If clinical or radiologic improvement does not occur 
within 1 to 2 weeks of begining empirical therapy, an alternative diagnosis 
should be sought using stereotactic brain biopsy.  
Primary Central Nervous System Lymphoma 
Primary  CNS lymphoma once considered to be rare is on the rise ,presenting in 
the late stage when the CD4 counts fall below 100.  [ 84, 85[86, 87]. Many 
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investigators have shown 100% association with EBV [88-92]. Cinque and 
associates [93] reported the diagnostic value of EBV DNA in CSF. 
SIMPSON AND TAGLITI, ANNALS,showed “Patients presented with 
confusion,  memory disturbance ,headache and focal neurologic deficits [84, 94-
96]. Radiology  may show ‘single / multiple homogeneously contrastenhancing 
lesions’.  It is difficult to differentiate lymphoma from toxoplasmosis with 
clinical and radiologic evidence [85.], The evidence of a single lesion on MRI, 
especially when sera is negative toxoplasma antibodies, favors the diagnosis of 
lymphoma [90].’ Thallium-201 single-proton emission computed tomography 
[91] and positron emission tomography’ [92] are help to differentiate. 
Stereotactic biopsy gives definitive diagnoses[85-87]. 
MR SPECTROSCOPY OF CNS LYMPHOMA IN A HIV PATIENT 
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CT BRAIN OF CNS LYMPHOMA (SINGLE LESSION)  
 
Primary CNS lymphoma occurring in AIDS carries a poor prognosis in 
untreated cases(median survival of < 1 month) [86, 87].However Radiation 
therapy improves neurologic outcome & quality of life in significant number of 
people [87, 88, 96] increasing the median survival by  4 to 6 months [77, 
96].Radiation therapy with chemotherapy have shown positive results in 
prospective clinical studies. 
Progressive Multifocal Leukoencephalopathy 
Progressive multifocal leuko encephalopathy (PML) is caused by reactivation of 
the JC (ie, polyomavirus)[97] and as many as 90% of healthy people are 
seropositive but only <10% have evidence of disease activity. In cases 
associated with the initiation of HAART and the immune recovery, pre-existing 
subclinical PML starts to manifest.  
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Berger and colleagues [98] noted “PML in 4% of patients with AIDS and was 
the initial manifestation of AIDS in 29% “.The area where the virus replicates is 
a matter of arguement, however it is proposed to be bonemarrow and 
reticoloendothelial ststem. Whether the virus in the CNS gets reactivated or the 
virus on entering the CNS is activated is a matter of dispute. 
Clinical Presentation 
Patients with progressive multifocal leukoencephalopathy (PML) presents as 
insidious onset and steady progression(over several weeks) with symptoms like 
behavioral, speech, cognitive, motor  and visual distrubance.(163) However, PML 
demonstrates relatively rapid progression compared to AIDS dementia complex 
(ADC). 
As individual lesions expand, either concentrically or along white matter tracts, 
manifestations may worsen and involve a larger territory . Although seizures 
have been considered a rare manifestation of PML. Lima et al found that 
seizures occurred in 18% of PML and many had demyelinating lesions 
immediately adjacent to the cortex. Seizures usually responded well to 
treatment and did not affect survival.In PML related to immune reconstitution, 
onset may occur weeks to months after the initiation of antiretroviral therapy. 
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Physical examination 
Focal neurologic signs like speech distrubance, weakness, difficulty in walking 
and balance, visual disturbance develop. Focal signs localizing  mainly to the 
occipital lobes are seen. Conjugate gaze distrubances are frequent, occurings as  
first presentation in 30% of cases. Quadriparesis and coma can also develop as 
the diseases progress. 
Computed tomography or magnetic resonance imaging 
1. CT scan or MRI shows single or multiple concurrent lesions in the absence of 
pressure effects,  mostly in subcortical  whitematter. Lesions below the 
tentorium tend to be asymmetrical. Gray matter below the cerebral cortex and 
spinal cord are sometimes affected. The close mimic are lymphoma, 
toxoplasmosis and HIV encephalitis [162]  
MRI OF A HIV PATIENT WITH PML 
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MR SPECTROSCOPY OF PML
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Lumbar puncture 
Cerebrospinal fluid (CSF) is usually normal.CSF PCR is  highly specific (99%) 
and sensitive (93%) for demonstrating the VIRUS. For patients on retroviral 
theraphy, the CSF viral load is indicator of the disease activity.  
BRAIN BIOPSY 
Histological testimonial for a definitive diagnosis is neccessary. It shows many 
areas of severe demyelination, intense perivascular inflammatory infiltrates with 
large “ballooned” oligodendroglial cells, with nuclear viral inclusions [99]. JC 
virus can be demonstrated in oligodendrocytes by insitu hybridization. 100, 
101].  
34 
 
Treatment & Management 
All treatments are experimental in progressive multifocal leukoencephalopathy 
(PML). The principal approach is antiretroviral therapy. Anecdotal case reports 
of use of pulsed methyl prednisolone have shown rapid improvement in IRIS-
associated PML.[163]  
Cryptococcal Meningitis  
Cryptococcus neoformans is a yeast covered by capsule, described  Busse, a 
pathologist[164]  Cryptococcus contains more than 50 types, but  
only C.neoformans and C. gattii are pathogenic to humans . Based on the 
capsular polysaccharide they divide into 5 serotypes( A, D, and AD of C 
neoformans and  B and C of C. gattii). C neoformans serotype A infections 
occurs in immunocompromised patients, including HIV patients. C gattii  
mostly affects  immunocompetent people, its response to treatment is relatively 
slow and have the tendency developing  intracerebral mass lesions.(164). 
SEROTYPE A is common worldwide. In india the prevalence is between 9%-
27% and is relatively under studied. 
 
C neoformans  causes an asymptomatic pulmonary infection.Meningitis can 
also be the first presentation. In the lungs it causes pneumonia, mass lesions, 
sometimes pleural effusion. Meningitis or disseminated infection is seen in 
immunodeficient patients,immunocompetent individual with pulmonary 
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manifestations alone.. Satishchandra etal study in bangalore revealed 
cryptococcal meningitis in 37% cases. Attili etal study showed 31% cases of 
HIV CNS manifestation was due to cryptococcus. Deshpanda etal and teja etal 
study found cryptococcal  meningitis in 17% and 10.5% cases respectively. 
Clinical symptoms 
It is the most comman fungal infection of the CNS. Subacute meningitis is the 
presentation and it is fatal with out theraphy.The course of the illness depend on   
the associated conditions like diabetes, sarcoidosis, steroid use) and also on the 
immune status of the individual.It usually presents as headache,altered mental 
status, confusion,and coma. Nausea and vomiting indicate increased intracranial 
tension, whereas fever and meningial sings indicate a more intense 
inflammatory reaction. Archnoiditis, cranial nerve neuritis, chorioretinitis, 
hydrochephalus can also develop. 
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CXR OF PATIENT WITH CRYPTOCOCCOSIS 
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LABORATORY STUDIES 
1. India ink stain. 
2. A CSF antigen titer >1:8 [104, 105], or a positive CSF culture [106, 107]. 
Cerebrospinal fluid opening pressure is elevated and may have important 
prognostic implications( visiual impairment) [108]. 
CNS CRYPTOCOCOSIS 
 
ANNALS states, Bad  prognostic factors are Altered mental status , increased 
CSF antigen titer, decreased CSF leukocytes , extrameningeal culture positive 
for the fungus and decreased serum sodium [104,105]. 
CRYPTOCOCCAL MENINGITIS 
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TREATMENT 
The Management goals are to decrease intracranial pressure, treat the acute 
infection and to prevent relapses. Lumbar punctures, shunt procedures and 
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drugs like  acetazolamide helps to reduce the intracranial tension. [109].Role of 
steroids is  contraversial. 
Amphotericin B (0.7 mg/kg body weight/day) with flucytosine (100 to 150 
mg/kg /day) for 2 to 3 weeks, continued with fluconazole (400 mg/d) for 8 to 10 
weeks is given . Fluconazole is shown to be as effective as amphotericin B in 
treating this fungal meningitis in HIV patients, though fluconazole causes 
delayed clearance of the fungus from the CSF [109,111,]. 
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CNS TUBERCULOSIS 
Central nervous system involvement accounts for nearly 1% of  TB cases. 
World Health Organisation  estimates “9.4 million incident cases as the global 
burden and 14 million prevalent cases , 1.3 million deaths among HIV-negative 
people  and 0.38 million deaths among HIV-positive people.Majority of  cases 
were in the South-East Asia(35%), African(30%) and Western Pacific 
regions(20%). An estimated 11–13% of incident cases were HIV-positive; the 
African Region accounted for approximately 80% of these cases”. “India, 
China, Indonesia, Nigeria, and South Africa rank first to fifth in the total 
number of incident cases”.  
Risk factors for CNS tuberculosis include1. age (children> adults)2. HIV-
coinfection, malnutrition measles in children135, alcoholism, malignancies, 
immunosuppressives and prevalence in the community134,135. HIV co infection 
is a strong predictor of rapid progression of the active TB(10% per year),. 
Inspite TBM is common in hiv patients , its course is not altered by 
HIV.Nonspecific headache with or without neckstiffness mark the onset of 
disease.Focal neurological deficits, behavioral abnormalities and distrubances in 
consciousness level develop along the course of the disease.136. A TB history is 
present  only in 10% of patients136chest X- ray changes in 30 to 50%. 
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Cerebro vascular complications of tuberculous meningitis(Tuberculous 
vasculopathy) presents  as multiple or bilateral lesions in middle cerebral artery  
territory and is due to  immersion of the artery in local inflammatory exudate. 
Cranial nerve palsies (mostly 6 th) occur in 20–30% of cases and can be the 
lone feature. Optochiasmatic arachnoiditis , third ventricular compression of 
optic chiasma , optic nerve granuloma all lead to vision loss. Ophthalmoscopic 
examination may shows papilloedema,choroid tubercles(indicating miliary 
tuberculosis and are virtually pathognomonic ).Other Cranial nerves can also be 
involved. Stoke can also occur along the entire course of the disease. 
TB Meningitis  
 
British Medical Research Council TBM grade (severity of TBM): 
1. Grade I TBM is defined as a Glasgow coma score of 15 , absent focal deficit. 
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2.  Grade II TBM as a Glasgow coma score of 15, presence of focal 
neurological deficit or a GCS of 11 to 14  
3.  Grade III TBM is defined as a Glasgow coma scale of ≤10. 
Rockie . et.al noted clinical presentations of tuberculoma or tuberculous 
abscess(140) depends mainly on their location, presenting mostly as headache, 
seizures, papilledema. The presentation of brain abscess is more subacute (1 
week to 3 months) than tuberculoma but slower than bac  terial brain 
abscesses132. Ahuja etal diagnostic criteria were used for diagnosis of TB 
meningitis. 
Investigations 
Definitive diagnosis of tuberculous meningitis demonstration of the tubercle 
bacilli in the CSF, (smear or by culture). Stains such as Ziehl Neelsen, Kinyoun 
or auramine rhodamine are used.Culture and sensitivity helps in choosing the 
antibiotic and also in prognosis. 
CSF typically has a pleocytosis, an increased protein level and marked 
decreased glucose levels. 
Chest radiography may show hilar lymphadenopathy, pneumonia, fibronodular 
infiltrate/cavitation, and pleural effusion. ADA is related  to lymphocytic 
proliferation and differentiation,(marker of cell-mediated immunity)141 . ADA 
has a sensitivity of 44% to 100% and specificity of 71 to 100%.143 Standard  
43 
 
ADA values for the diagnosis of TBM are yet to be established.A range from 
>5.0 to >15 IU/liter is used in most studies. ADA activity lacks specificity but 
can predict prognosis. Raised CSF ADA activity is also seen in malaria, 
brucellosis,bacterial meningitis, cryptococcal meningitis, and cerebral 
lymphomas145. 
 
Brain and Spinal Imaging 
CT scanning and MRI of the brain reveal hydrocephalus, basilar meningeal 
thickening, infarcts, edema, and tuberculoma , and also in monitoring 
complications that require neurosurgery. 
CT BRAIN Showing Basal Meningitis  
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MRI Showing Tuberculoma  
 
Basal cisterns  enhance strikingly(quadrigeminal cistern, interpeduncular fossa, 
ambient cisterns).There is enhancement of meninges in HIV patients. 
Enhancing nodular lesion with central hypodensity is typical of 
tuberculoma[156] 
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CNS Tuberculoma  
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Treatment of CNS TB 
The recommended first-line  agents for all forms of CNS tuberculosis are 
Isoniazid, Rifampicin, Pyrazinamide and Ethambutol taken daily either 
individually or in combination form. 
Patients should be treated for a minimum of 10 months. In cases of failure to 
respond or interruption it can be for 12 months. INH has a good CSF 
penetration and early bactericidal activity . At standard doses isoniazid achieves 
CSF levels 10–15 times the minimum inhibitory concentration of M. 
tuberculosis148. The disadvantages being drug resistance when used as 
monotherapy though it does occur for chemoprophylaxis. Pyridoxine is used to 
treat INH ovredose( stops seizures, reverses coma and corrects the metabolic 
acidosis).The standard dose is 1 mg of pyridoxine for every mg of isoniazid, 
given as rapid intravenous infusion149. Prompt treatment is given as it is very 
fatal(fatal dose- 90 mg/kg) 150. Rifampicin slightly less CSF penetration 
(maximum concentrations around 30% of plasma), but the high mortality from 
rifampicin resistant TBM has confirmed its key role in the treatment of CNS 
disease151. 
 The incidence of ethambutol induced optic neuritis is less than 3% (standard 
dose of 15–20 mg/kg), though it is a concern especially when treating comatose 
patients152. Fluoroquinolones are an effective fourth agent (if ethambutol is 
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contraindicated), but  contraindicated in pregnant or breastfeeding women and 
children153.  
All patients with TBM may receive adjunctive corticosteroids regardless of 
disease severity(154) at presentation. Adults (>14 years) should start treatment 
with dexamethasone 0.4 mg/kg/24 hours tapered over 6 to 8 weeks. Children 
(d″14 years) should be given(154) prednisolone 4mg/kg/24 hrs (or equivalent 
dose dexamethasone: 0.6 mg/kg/24 hrs) for 4 weeks, tapered  over 4 weeks. 
CO EXISTANT TUBERCULOMA AND MENINGITIS 
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Neurocysticercosis 
Neurocysticercosis  is caused by Taenia solium and is the most common 
helminth infection of the central nervous system . It is endemic in areas where 
pigs are reared.  The number,size, and location of cystic lessions and  immune 
response determine the presentation of the disease. It accounts for 27% of CNS 
lesions in HIV patients  with neurologic manifestations. There is very little 
information about the relation between NCC and HIV infection. Parija etal 
study in jipmer revealed  seropositivity 5% in 100 hiv positive patients.  
The accurate clinical diagnosis of  neurocysticercosis  in HIV is difficult due to 
deranged immunological parameters. Cysticerci can be found anywhere in the 
body(brain, cerebrospinal fluid , muscle). Neurologic manifestations are the 
most common . Seizures(generalized, focal, or Jacksonian )are associated with 
inflammation around  cysticerci in the  suurounding brain tissue. 
Hydrocephalus(communicating), papilledema results from obstruction csf by 
cysticerci and arachnoiditis. Stroke and chronic meningitis are also reported.Del 
brutto etal (167) diagnostic criteria were used for diagnosis of 
neurocysticercosis 
For the treatment of patients with brain parenchymal cysticerci, antiparasitic 
drugs, including albendazole (15 mg/kg per day for 8–28 days) or praziquantel 
(50–100 mg/kg daily in three divided doses for 15–30 days must be given. 
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ACUTE TRANSVERSE MYELITIS 
Transverse myelitis (TM) is a neurologic syndrome caused by inflammation of 
the spinal cord.It is a unusual manifestation of hiv infection. 
Transverse Myelitis Consortium Working Group(168)   Proposed   diagnostic 
criteria for idiopathic  acute transverse myelitis. 
LERNER.”DEMYELINATING DISORDERS”, 
 “CURRENT CLINICAL NEUROLOGY.2006 GIVES “  
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INCLUSION CRITERIA 
Development of sensory, motor, or autonomic dysfunction attributable to the 
spinal cord , Bilateral signs and/or symptoms (though not necessarily 
symmetric),Clearly defined sensory level, Exclusion of extra-axial compressive 
etiology by neuro imaging (MRI or myelography) ,Inflammation within the 
spinal cord demonstrated by CSF pleocytosis or elevated IgG index or 
gadolinium enhancement. If none of the inflammatory criteria is met at 
symptom onset, repeat MRI and lumbar puncture evaluation between 2 and 7 d 
following symptom onset meet criteria Progression to nadir between 4 h and 21 
d following the onset of symptoms (if patient awakens with symptoms, 
symptoms must become more pronounced from point of awakening). 
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EXCLUSION CRITERIA: 
History of previous radiation to the spine within the last 10 yrs. Clear arterial 
distribution clinical deficit consistent with thrombosis of the anterior spinal 
artery, Abnormal flow voids on the surface of the spinal cord consistent with 
AV Malformation, Serologic or clinical evidence of connective tissue disease.  
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MATERIALS AND METHODS 
 
A prospective study was conducted about CNS MANIFESTATIONS IN 
HIV/AID at THANJAVUR MEDICAL COLLEGE. THANJAVUR, from 
JANUARY 2012 to October 2012. All HIV/AIDS patients admitted in TMCH 
with CNS manifestations included in this study. 
 
SELECTION OF CASES 
 HIV seropositive patients 
 Greater than 14 yrs of age 
 Presenting with CNS manifestations 
 
PATIENT WORK UP 
A Performa was developed and supplied to all concerned departments. The 
Detailed history of patient’s illness, findings of clinical examination, routine 
investigation reports pertaining to the disease and special investigation reports 
were collected and entered in the Performa.  
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PROFORMA 
FEVER 
 
HEADACHE 
 
VOMITING 
 
MENINGEAL SIGNS 
 
PYRAMIDAL SIGNS   
 
OTHER 
NEUROLOGICAL 
MANIFESTATIONS 
 
Papillodema 
 
Co-Existing Illness 
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CT SCAN / MRI  : 
 
 
RING ENHANCING LESIONS 
 
 
TOXOPLASMA Ig G   
 
 
NEURO CYSTICERCOSIS ANTIBODY 
CSF EXAMINATION 
 
 
CSF FINDING 
 
 
ACID FAST STAIN 
 
 
INDIAN INK STAIN 
 
 
FUNGAL CULTURE 
 
 
CSF   VDRL 
DIAGNOSIS TREATMENT 
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DIAGNOSTIC CRITERIA 
DIAGNOSTIC CRITERIA FOR TB MENINGITIS 
Diagnosis of TB meningitis is done with history (subacute illness), CSF 
findings (↑protien level, lymphocytic plecytosis and demonstration of AFB).  
Sputum examination, x-ray chest, FNAC of lymph nodes, USG abdomen 
positive cases strongly supports the diagnosis particularly in space occupying 
lesions. Ahuja etal diagnostic criteria (165) were used for categorization of TB 
meningitis patient. 
I. Clinical symptoms and signs 
Mandatory:   Fever and headache >2 weeks 
Optional:       Vomiting, neck stiffness, altered sensorium, seizures or focal 
Neurologic deficit 
 Supporting criteria 
1. CSF:       Cells : >20/cmm, lymphocytes : >60%, proteins: 100 mg%, sugar: 
<60% of corresponding blood sugar, negative gram stain, India stain and 
VDRL where relevant 
2. CECT/MRI   Showing one or more of: exudates in basal cisterns / Sylvian 
fissures, gyral enhancement, hydrocephalus. Infarcts, tuberculoma. 
3. Active extraneural TB :   as evidenced by appropriate mycobacterial tests, 
radiology, histopathological examination 
4. Clinical response to ATT and relief of symptoms 
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DIAGNOSIS OF CNS TUBERCULOMA 
CNS Tuberculoma  were diagnosed by evidence of concomitant TB  
meningitis,radiological or bacteriological evidence of pulmonary or extra 
pulmonary TB, negative serological test for toxoplasma and neurocysticercosis   
and respond to antitubercular therapy. 
M.Tuberculosis on staining appears long, filamentous, club shaped with beaded 
or barred forms. On culture forms rough raised irregular colonies with a 
wrinkled appearance it is slow growing, non pigmented, niacin test and nitrate 
reduction test positive catalase test weakly positive. 
DIAGNOSIS OF CRYPTOCOCCAL MENINGITIS 
Crypto coccal meningitis is diagnosed by Indian ink method or culture 
demonstrating organism.  Indian ink stain demonstrate the capsule which is seen 
as an unstained halo around  the organisms distributed in a black background. 3. 
In culture, Crypto coccus neo formans   appears as creamywhite to yellowbrown 
colonies. Wellcapsulated strains appear glistening because of their 
mucous.Poorly encapsulated strains look dry.  
DIAGNOSIS OF CNS TOXOPLASMOSIS 
CNS Toxoplasmosis was diagnosed by CT/MRI showing multiple ring 
enhancing lesions,raised igG levels and responds to treatment. 
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DEL BRUTTO ETA CRITERIA(167) FOR  DIAGNOSIS OF 
NEUROCYSTICERCOSIS 
1. Absolute criteria 
a. Demonstration of cysticerci by histologic or microscopic examination of 
biopsy material 
b. Visualization of the parasite in the eye by funduscopy 
c. Neuro radiologic demonstration of cystic lesions containing a 
characteristic scolex 
2. Major criteria 
a. Neuro radiologic lesions suggestive of neurocysticercosis 
b. Demonstration of antibodies to cysticerci in serum by enzyme-linked 
immune electro transfer blot 
c. Resolution of intracranial cystic lesions spontaneously or after therapy 
with albendazole or praziquantel alone 
3. Minor criteria 
a. Lesions compatible with neurocysticercosis detected by neuroimaging 
studies 
b. Clinical manifestations suggestive of neurocysticercosis 
c. Demonstration of antibodies to cysticerci or cysticercal antigen in 
cerebrospinal fluid by ELISA 
d. Evidence of cysticercosis outside the central nervous system (e.g., cigar-
shaped soft-tissue calcifications) 
58 
 
4. Epidemiologic criteria 
a. Residence in a cysticercosis-endemic area 
b. Frequent travel to a cysticercosis-endemic area 
c. Household contact with an individual infected with Taenia solium  
 
Acute transverse myelitis is diagnosed by transverse myelitis consortium 
working group (168) proposed diagnostic criteria except inclusion of HIV in the 
criteria. 
CRITERIA FOR DIAGNOSIS OF CARIE, S SPINE (177) 
• Signs and symptoms consistent with tuberculosis 
• Clinical features of spinal cord compression, 
• Complete or partial collapse of one or more vertebrae on X-ray spine and 
• One of the criteria (a to e) shown below 
• Magnetic resonance imaging (MRI) or CT spine showing destruction 
of intervertebral disc and adjoining vertebrae causing compression of 
spinal cord or myelography with obstruction at the level of vertebral 
collapse as seen on plain X-ray of the spine.  
a. History of TB in the family 
b. Chest x-ray (CXR) consistent with tuberculous infection of lungs 
c. Induration of > 10 mm with Tuberculin skin testing after 48 to 72 hours 
irrespective of prior Bacillus-Calemette-Guerin (BCG). 
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d. Response to antituberculous therapy OR Mycobacterium tuberculosis 
(MTB) detected on polymerase chain reaction (PCR) OR Isolation of 
MTB from CSF or gastric aspirate on acid-fast stain or culture.  
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Table-1 
AGE distribution 
 
Age group Case (n=40) 
14-29 9 
30-39 20 
40-49 10 
50-59 1 
>60 0 
Mean 35.2 
S.D 9.4 
 
Table-1 shows age distribution of HIV (+) patients with neurological 
manifestations. Majority of patients were in age group of 30-39 years with mean 
age of 35.2 years and S.D (9.4)    
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TABLE 2 
SEX DISTRIBUTION 
SEX CASE 
Male 28(70%) 
Female 12(30%) 
 
Gender distribution shows that out of 40 patients 28 (70.0%) patients were 
males and 12(30%) patients were females with male female ratio 2.3:1 
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Sex distribution
males 
females74.8%
24.2%
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TABLE-3 Revealed clinical profile of patients presented with neurological 
manifestation. Presence of fever indicates either TB meningitis or cryptococcal 
meningitis. Headache is fairly common in all our patients except spinal cord 
involvement. Presence of focal neurological deficit argue in favor of 
toxoplasmosis,stroke. CNS tuberculoma patients presented with a higher 
incidence of focal neurological deficit compared to TB meningitis.  22% 
patients with TBM have multiple cranial nerve palsy. Meningeal signs were 
present in 77% patients with TBM and 66% patients with cryptococcal 
meningitis. Seizure was a predominant symptom in patients presented with 
space occupying lesions.Altered sensorium was more common in CCM (66.6%) 
patients compared to TBM (40.9%) Toxoplasmosis (50%), CNS tuberculoma 2 
(50%). About 33.3% patients with CCM had papilloedema. Out of 4 patient of 
CNS tuberculoma 2 had papilloedema and out of 2 patients of toxoplasmosis 1 
had papillodema. All 3 Neurocysticercosis patients presented with seizures. 
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TABLE-4 
 
NEURODIAGNOSIS PERCENTAGE 
TB MENINGITIS 22(55%) 
CRYPTOCOCCUS MENINGITIS 3(7.5%) 
CNS  TOXOPLASMOSIS 2(5%) 
STROKE 2 (5%) 
PML 1(2.5%) 
NEUROCYSTICERCOSIS 3(7.5%) 
CNS TUBERCULOMA 4(10%) 
CARIES SPINE PARAPLEGIA 2(5%) 
ATM 1(2.5%) 
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TABLE-4 Shows distribution of cases in HIV patients with CNS manifestation 
in our study. Of the 40 cases TB meningitis was the most common CNS 
infection (55%), cryptococcal meningitis(7.5%). Of the various space 
occupying lesions CNS tuberculoma (10%) was most predominant,followed by 
toxoplasma(5%), Neurocysticercosis(7.5%). There were 2 patients with stroke 
(5%) that could be caused by the virus itself.Two cases of Caries spine were 
diagnosed both of them presented with compressive myelopathy. Progresive 
multifocal leukoenchepalopathy (PML) was found in 1 (2.5%) patient and 1 
case of acute transverse myelitis (ATM) was reported.     
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TABLE-5 
CSF 
FINDING 
CCM 
3 
TBM 
22 
CNS 
TUBERCULO
MA  2 
TOXOPLA
SMA 
2 
PML 
CELLS/MM3 13.3 ± 
6.11 
109.1  ± 
48.5 
75 ± 7.07 8 6 
neutrophil 2.6 ± 2.30 29.3 ± 14.9 15 ± 7.17 0 0 
Lymphocyte 10.6 ± 
4.61 
79.4 ± 37.9 60 ± 14.14 8 6 
protein 75.3 ± 
5.033 
212.2 ± 
61.77 
145 ± 7.07 70 90 
sugar 34 ± 2.00 33.8 ± 5.78 35 ± 4.24 52 48 
Indian ink 3     
All our patients with TB meningitis had marked Lymphocytic pleocytosis 
(mean cell count of 109.1 ± 48.5), Lymphocyte count (79.4 ± 37.9) with raised 
71 
 
protein levels (212.2 ± 61.77). In cryptococcal meningitis although pleocytosis 
was seen, it was low as in compared to TBM (13.3 ± 6.11).  There was a mild 
raise in protein content (75.3 ± 5.33), CSF sugar levels were low (34 ± 2). Out 
of 2 patients of toxoplasmosis 1 was without papillodema and undergone CSF 
study which was normal.  Out of 4 CNS tuberculoma patient 2 were without 
papillodema and undergone CSF study which revealed elevated protein levels 
and lymphocytic pleocytosis. 
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TABLE-6 
CORRELATION WITH CD4 COUNT 
 <200 200-350 >350 
CNS TB 13 9 4 
CCM 2 1 0 
CNS TOXOPLASMOSIS 2 0 0 
PML 0 1 0 
STROKE 1 1 0 
CARIES SPINE 0 1 1 
Neurocysticercosis 0 2 1 
ATM   1 
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TABLE-6 Shows correlation of various CNS manifestations in HIV patients in 
our study with their respective CD4 count.  Among CNS TB cases 50%cases 
had CD4<200, 34.61% cases had CD4 count 200-350, 15.38% cases had CD4 
count >350. Among crypticoccal meningitis 66.66% cases had CD4 count<200 
and 33.33% cases had CD4 count>200. All the patients of CNS toxoplasmosis 
had CD4 count<200. Out of 3 cases of neurocysticercosis 2(66.66%) patients 
had CD4 count between 200-350 and one (33.33%) patient had CD4 count 
above 350. Out of 2 patients of caries spine with paraplegia one(50%) patient 
had CD4 count between 200-350, One (50%)patient had CD4 count above 
350.Case of acute transverse myelitis revealed CD4 count>350.. Out of 2 cases 
of hiv related stroke 1 had CD4 count<200 and 1 had CD4 count above 200.  
CORRELATION WITH CD4 COUNT  
0 5 10 15 20
<200
200-350
>350 TBM
CCM
TOXOPLASMOSIS
NEUROSYPHILIS
STROKE
CARIES SPINE
ATM
NEUROCYSTICERCOSIS
 
PML 
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Table-7 
MEAN LEVEL OF CD4 ACC0RDING TO NEURODIAGNOSIS 
 
CNS INFECTION CD4   MEAN+_S.D 
CNS TB 217.7_+119.29 
CRYPTOCOCCAL INFECTION 130.0+_72.02 
TOXOPLASMA INFECTION 104+_82.2 
PML 286 
STROKE 205+_38.18 
CARIES SPINE 299+-123.03 
NEUROCYSTICERCOSIS 323.3+_110.02 
ATM 562 
 
Mean CD4 count of CNS TB was 217.7  with 68% values were between108-
336. Mean CD4 count of Cryptococcal meningitis was 130 with 68% values 
between58-202.Mean CD4 count of  HIV  related stroke was 205 with 68% 
values between167-233.Case of progressive multifocal leukoenchepalopathy 
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had CD4 count 286.Neurocysticercosis cases presented with  mean  CD4 count 
323, acute transverse myelitis had CD4  count 562.Toxoplasmosis cases had 
mean CD4  count 104.  
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Table - 8 
Correlation of CNS TB with pulmonary & Extra pulmonary TB 
  CNS TB(n=27) 
PULMONARY TB SPUTUM(+)         04 
 SPUTUM(-)         04 
EXTRAPULMONARY  
TB 
TB LYMPHADENITIS         02  
 INTESTINAL TB         03  
 TB PERICARDITIS         01 
 
Table-8 shows correlation of  CNS TB  with pulmonary & extrapulmonary 
TB.Out of 26 cases detected as CNS TB 8 patients also suffered simultaneously 
from PTB.Out of them 4 patients were positive for sputum AFB 4 patients had 
radiological evidence of PTB.2 patients had evidence of TB lymphadenitis,stool 
AFB  were positive for 3 patients.One patient had TB pericarditis.  
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DISCUSSION 
A prospective study on CNS MANIFESTATIONS IN HIV/AIDS was carried 
out at Medicine department of, THANJAVUR MEDICAL COLLEGE, 
THANJAVUR from JAN 2012 to OCT 2012.  All   HIV/AIDS patients 
admitted in TMCH with CNS manifestations were included in this study.  
The sample size consisted of 40 HIV + patients presented with various 
neurological manifestations affecting brain and spinal cord. 
Among cases majority were in age group of 30-39 years (mean- 35.2 years 
;S.D- 9.6 ).Earlier studies done also supports the fact that the mean age group 
affected was between 31.6 – 40.9. 
The present study showed a male preponderance with 28 males and 12 females 
(male female ratio 2.3:1). Males had also outnumbered females in similar 
studies done earlier .Study done by attili etal  in BHU  Varanasi (32)  2001-
2003 revealed male female ratio 3.7: 1. Teja etal study (24) in NIMS revealed 
male to female ratio 3.9:1. Alaka etal study (160) showed male:female  ratio 
2.3:1.    
Our gender distribution parallels the demographic pattern of hiv infection in 
india(M: F=3:1). Predominance of Male cases may be due to migration to urban 
areas for job, staying away from families and promiscuous sexual habits 
resulting in acquiring HIV infection .Generally females particularly of low 
socioeconomic status who tend to avoid health check ups leading to a low 
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detection rate. More and more females are being infected through hetero sexual 
mode of transmission as the epidemic expands.  
Clinical profile of patients presenting with neurological manifestation revealed 
around 90% patients presented with TB meningitis had fever and headache.attili 
etal[32] reported fever in 90% and headache in 80% cases. Meningeal signs and 
papillodema were present in 77.7% ,36.3% patients respectively. Focal 
neurological deficit and seizure were present in (18.2%),(18.1%) patients 
.Exudate within subarachnoid space is the primary pathological lession, more 
prominent at the base. This leads to inflammation of adjacent blood vessels and 
occlusion. Cerebral infarction, resulting from vascular occlusion, is a common 
sequele most often found in the distribution of the middle cerebral artery and 
striates arteries as they penetrate the base of the brain. CT scan revealed lacunar 
infarct in MCA territory in 2 patients.  
According to various studies seizures are the initial presenting manifestation  in 
10-15%cases. Cranial nerve palsy was present in (22.7%) of our patients. 
Various literatures shown cranial nerve palsy in 20-30% cases. Sixth cranial 
nerve was most commonly affected. 
Cryptococcal meningitis patients presented with headache in (100 %) cases and 
fever in (66.6%)cases. Meningeal signs and papillodema were present in 
(66.6%),(33.3%) cases respectively. Attili etal study reports meningeal signs in 
(87.5%) cases and papillodema in 50% cases. Lower incidence of meningeal 
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signs in our study may be because of the altered immune defences with minimal 
inflammatory reaction in AIDS patients. Seizures were present in (33.3%) 
cases. Focal neurological deficit were observed in our patients. Attili etal study 
showed neurological deficit in 15% cases.and seizure in 50% cases. 
Headache was present in all 4 cases of CNS tuberculoma. Seizures, focal 
neurological deficit, papilloedema were found in 50% cases. M .wasay etal 
study (170) of 102 patients diagnosed cases of CNS tuberculoma in Pakistan 
found fever (59%),headache (57%) cases, meningeal irritation in  35% cases. 
Out of 2 cases of CNS toxoplasmosis headache and focal neurological deficit 
were present in both cases. Seizures and papillodema were present in 50% 
cases. Various literatures shown   that headache (55%) and focal neurological 
deficit (69%) as the predominant finding. 
We had 2 cases of stroke both were young with age< 50 years. One patient 
presented with hemiparesis and other monoparesis.Case of progressive 
multifocal leukoenchepalopathy presented with headache and worsening loss of 
conciosness and all 3 cases of neurocysticercosis patients had seizures .Acute 
transverse myelitis and caries spine cases   presented as cases of paraplegia. 
Out of 40 patients 27 had CNS TB (67.51%), 55% patients had TB meningitis, 
10 % patients had CNS tuberculoma, 5 % had caries spine. Our study revealed 
CNS TB most common cause of neurological manifestations in HIV patients. 
Attili etal study in Varanasi (32) found TB meningitis in 52% cases and CNS 
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tuberculoma in 4% cases. Satish Chandra etal study in NIMHANS (169) found 
CNS TB IN 36% cases. Deshpandal study (160) in Bombay showed out of 300 
cases with HIV CNS manifestation 48 were due to CNS tuberculoma and 24 
cases due to TB meningitis. Rakendra singh etal study in Punjab reported CNS 
tuberculosis in 65.5% of cases. Studies from western studies show a lesser 
tuberculosis compared to Indian studies probably because of the increased 
prevalence of tuberculosis in our country.(According to WHO report 40% (171)  
Indian population are infected with tuberculosis and INDIA contributes  20% 
world TB cases).  
Cryptococcal meningitis was present in 7.5% cases.Prevalence was  lower 
compared to other studies in India. Satishchandra etal study revealed 
cryptococcal meningitis in 37% cases. Deshpanda etal and teja etal study found 
cryptococcal   meningitis in 17% and 10.5% cases respectively.  Studies from 
various parts of the world show contrasting prevalence rates with marked 
geographical variations. In sub-Saharan Africa, meningitis due to cryptococcas 
is more frequent than tuberculosis. 
CNS toxoplasmosis was found in 5% cases. Attili etal study shown 
toxoplasmosis in 10% cases.Satishchandra et al and teja etal study revealed 
toxoplasmosis in 13% and 9% cases respectively.Deshpandey etal study in 
Bombay revealed toxoplasmosis in 20% cases.They found toxoplasmosis as the 
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most common cause of CNS infection. Study done in brazil (8) shown 
toxoplasmosis in ( 42.3%)  cases. 
First national serological prevalence of Toxoplasma gondii in India done in2007 
by M. dumni etal (162). In total, 23,094 serum samples were tested, toxoplasma 
igG  were found in 24.3%  cases. sero prevalence was 31.5% in 
Maharashtra,21.5% in tamil nadu, 21.2 % in Orissa,15.8% cases in delhi. 
Lowest sero prevalences were in  northern parts of India, probably reflect the 
effects of significantly drier conditions and, therefore, a negative impact on the 
survivability of T. gondii oocysts.This probably explains high incidence of CNS 
toxoplasmosis in Bombay based study .In south American countries toxoplasma 
serology prevalence is 40-60%.  
Stroke related to HIV virus infection was found in 5% cases. Deshpandey etal 
study shown stroke in 5% cases. Rakendra singh etal sudy done in Punjab 
revealed stroke in 1.44 % cases.We had two cases of stroke.HIV induced 
vasculitis, prothrombotic state( anticardiolipin Ab, decreased protein S level and  
dysfunctional heparin cofactor 2 level) leads to stroke syndrome. 
Our study revealed three cases of neurocysticercosis. Adequate data regarding 
the rate of this co-infection is lacking. Parija etal study (173) in 
Jipmer,Tamilnadu. revealed seropositivity 5% in 100 HIV positive patients. Our 
patients were from ARIYALUR district .Altered immunological parameters 
make the diagnosis of neurocysticercosis difficult in patient with HIV .The 
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disease is under reported in India and systematic population-based studies are 
lacking (178).  However an association between the CD4 counts and  
neurocysticercosis could not be arrived with this limited data. 
Tubercular meningitis was marked by lymphocytic pleocytosis(mean count = 
109.1+_48.5) ,lymphocyte count(79.4+_37.9) with raised protin 
levels(212.2+_61.77. neutrophil count was( 29.3 +- 14.9).Sometimes the 
lymphocytopenia of advanced diseases leads to low lymphocyte counts in the 
CSF. 
In  cryptococcal meningitis mild pleocytosis (13.3+_6.11) with mild elevation 
in protein  (75.3+_5.03),low CSF  sugar levels (34.2+_2) are seen.Out of 2 
patients of toxoplasmosis 1 was without papillodema and undergone CSF  study 
which was normal.Out of 4 CNS  tuberculoma patient 2 were without 
papillodema and undergone CSF  study which revealed elevated protein levels 
and lymphocytic pleocytosis indicating  concomitant tuberculous meningitis  
supporting the diagnosis of CNS tuberculoma. Retrospective study of 102 CNS 
tuberculoma patients at a territory care level in Pakistan (170) with CSF 
analysis in 63 patients showed elevated protein(88%),low 
glucose(83%),pleocytosis(84%). 50% had clinical or biochemical evidence of 
concomitant TB meningitis. Even though the sample size is too small, we got a 
conclusion that all the patients with space occupying lesions without 
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papillodema should undergo CSF study particularly in our state where 
prevalence of TB is high. 
Our study demonstrated a higher incidence of CNS manifestations at a low CD4 
count. Among cases 18 patients had CD4 count <200,15 patients had CD4 count 
within 200-350, and 7 patients had CD4 count > 350. Out of 26 patients of CNS 
TB 50% had CD4 count <200, 7% cases had CD4 count 200-350,3%cases had 
CD4 count > 350.Mean level of CD4 count was 217.7 +- 119.29. It indicates the 
presence of TB in all stages of HIV diseases. CD4 count of the TB patients were 
variable from 26-562. CNS TB in HIV patients from endemic places occurs 
over a wide spectrum of CD4 counts and caries a good prognosis than other 
AIDS defining illness. Studies revealed increased mortality rate of CNS TB 
with low CD4 count. 
Cryptococcal meningitis were associated with mean CD4 count of 130+_72., 
CNS toxoplasmosis with mean CD4 count 104 +-82.2. Inclusion of both 
diseases under AIDS defining illness is justified .Mean CD4 count of HIV 
related stroke were 205.Deshpande etal study shown a mean CD4 count of 212. 
Acute transverse myelitis occurred at a CD4 count of 562.Polyclonal 
hypergammaglobulinemia of early diseases causes demyelinating and 
inflammatory disorders.PML was associated with a CD4 count of 286 and 3 
cases of  neurocysticercosis with mean CD4 count of 323. 
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Out of 22 patients of TB meningitis 45.4% patients had grade 1 TBM according 
to clinical findings, with a mean CD4 count of 238. 31.8% patients were in 
grade 2 category with mean CD4 count of 192.8. 22.8% patients were in grade 3 
category with a mean CD4 count of 152.4. It indicates patients presented with 
TBM and AIDS with lower CD4 count had more severe clinical manifestations 
and had bad prognosis than patient presented with TBM in earlier stages of HIV 
infection.Corbett elal study of HIV virus and prevalence of TB in African gold 
miners (175) shown that the marked reduction in life expectancy of advanced 
diseases shortens the duration of tuberculosis. Badri etals (176) prospective 
cohort study of TB-HIV  coinfection shown that 67% TB cases occurred in CD4 
level > 200/mm3 and patient survival in pulmonary and extrapulmonary TB was 
comparable to other benign illness . 
Out of 27 cases detected as CNS TB 8 patients also suffered simultaneously 
from PTB.Out of them 4 patients were positive for sputum AFB, 5 patients had 
radiological evidence of PTB.2 patients had evidence of TB lymphadenitis,stool 
AFB  were positive for 3 patients,one patient had TB pericarditis. Thus our 
study substantiates the theory of decrease in sputum AFB detection rate and 
increase in incidence of EPTB with progression of HIV infection.  
 
  
85 
 
CONCLUSION 
A prospective study on CNS MANIFESTATIONS IN HIV/AIDS was carried 
out at Medicine department of TMCH, During the 2 year’s 162 cases of 
HIV/AIDS were admitted in our hospital out of which neurological 
manifestations constitutes 40 cases (24.6%). Detailed history,clinical 
examination,routine blood investigations, CSF study, Toxoplasma 
serology,Neurocysticercosis IgM antibody, CT/MRI, sputum examination,X-
RAY chest ,FNAC of peripheral lymph nodes, CD4 count estimation  were 
done according to protocol. 
The various neurological manifestations in our studies were TB meningitis 
(55%), CNS tuberculoma (10%), Cryptococcus meningitis (7.5%), 
Neurocysticercosis (7.5%), Stroke (5%),CNS toxoplasmosis (5%), caries spine 
with paraplegia (5%), PML (2.5%), acute transverse myelitis (2.5%). 
Average CD4 count in CNS TB was 217.7, Cryptococcal meningitis patients 
had mean CD4 count of  130,CNS toxoplasmosis patients presented with mean 
CD4 count of 104, stroke patients had mean CD4 count of 205, CD4 count in 
Neurosyphilis was 286,neurocysticercosis patients with mean CD4 count of 
323, acute transverse myelitis with 562. 
The incidence of PTB in our study was 29.6%, intestinal TB (11.1%), TB 
lymphadenitis (7.4%), TB pericarditis (3.7%).  
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1 PANEER SELVAM 1394001 49 M Y 212
2 RAMU 1388074 41 M Y 133
3 MANOHARAN 1390758 49 M Y 129
4 SUBRAMANIAN 1388103 48 M Y 156
5 GANESAN 1416545 49 M Y 296
6 VADIVEL 1354671 48 M Y 286
7 JAYARAMAN 1417625 49 M Y 168
8 SUBRAMANIAN 1415848 47 M Y 155
9 SHAHUL HAMEED 1377314 35 M Y 185
10 ANBALAGAN 1415854 36 M Y 189
11 SHANMUGAM 1414214 35 M Y 160
12 RAMESH 1389595 35 M Y 185
13 KOLANJI 1388843 30 M Y 189
14 MURUGESAN 1365137 38 M Y 189
15 MOOKAIYAN 1364477 35 M Y 177
16 YESUDASS 1375600 38 M Y 562
17 SURESH 1418117 37 M Y 168
18 MURUGESAN 1415824 35 M Y 198
19 RANGAN 1407993 30 M Y 26
20 MUTHU 1368461 29 M Y 180
21 VIJAYAKUMAR 1394049 20 M Y 296
22 CHINNADURAI 1370070 26 M Y 312
23 KALIMUTHU 1371950 26 M Y 340
24 VAITHIYANATHAN 1391072 26 M Y 756
25 SETHU 1365836 25 M Y 948
26 SELVARAJ 1469978 29 M Y 410
27 MURUGESAN 1365137 27 M Y 120
28 SURESH 1364789 24 M Y 419
29 MALLIKA 1369557 38 F Y 256
30 SUBULAKSHMI 1365352 45 F Y 278
31 ANNAM 1365355 40 F Y 348
32 KANNAKI 1314235 35 F Y 312
33 SHAKUNTHALA 1400530 52 F Y 296
34 SELVI 1421085 38 F Y 312
35 SUMATHI 1376184 30 F Y 86
36 MARIAMMAL 1391872 30 F Y 268
37 KAVITHA 1378125 35 F Y 418
38 SUBULAKSHMI 1365352 35 F Y 299
39 CHITHRA 1387521 35 F Y 356
40 PUSHPAVALLI 1394177 33 F Y 250

                                                                      ABBREVIATIONS 
 
 
CNS  -    CENTRAL NERVOUS SYSTEM 
HAD -    HIV ASSOCIATED DEMENTIA 
PML -    PROGRESSIVE MULTIFOCAL LEULOENCEPHALOPATHY 
TBM -   TUBERCULOUS MENINGITIS 
ATM - ACUTE TRANSVERSE MYELITIS 
CCM - CYPTOCOCCAL MENINGITIS 
NCC - NEUROCYSTICERCOSIS 
HAART – HIGHLY ACTIVE ANTI RETROVIRAL THERAPY 
CMV – CYTOMEGALOVIRUS  
VCZ – VARICELLA ZOSTER 
HSV - HERPES SIMPLEX VIRUS 
CSF - CEREBROSPINAL FLUID 
PET – POSITRON EMISION TOMOGRAPHY 
ADC – AIDS DEMENTIA COMPLEX 
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